SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide. SET and MYND domain-containing protein 3 (SMYD3) has been shown to promote the progression of various types of human cancers, including liver cancer; however, the detailed molecular mechanism is still largely unknown. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Heyun, Zheng, Zhangyu, Zhang, Rongqin, Yan, Yongcong, Peng, Yaorong, Ye, Hua, Lin, Lehang, Xu, Junyao, Li, Wenbin, Huang, Pinbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302584/
https://www.ncbi.nlm.nih.gov/pubmed/34301921
http://dx.doi.org/10.1038/s41419-021-04009-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302584/
https://www.ncbi.nlm.nih.gov/pubmed/34301921
http://dx.doi.org/10.1038/s41419-021-04009-8

Ejemplares similares